[email protected]

About Juniper Point

This author has not yet filled in any details.
So far Juniper Point has created 5 blog entries.

Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers

Juniper Point2023-12-01T00:56:24+00:0011.29.2023|

Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community

Juniper Point2023-12-01T00:56:25+00:0011.21.2023|

Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Juniper Point2023-12-01T00:56:25+00:0011.03.2023|

Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting.

Download PDF Two poster presentations highlight Phase 1 data for [...]

Juniper Point2023-03-20T16:12:29+00:0004.01.2022|

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

Jan 5, 2022 Download PDF Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), [...]

Juniper Point2023-03-20T16:12:30+00:0001.05.2022|